MARCHESE, GIORGIO
MARCHESE, GIORGIO
Istituto di Farmacologia Traslazionale - IFT - Sede Secondaria di Pula (CA)
Alkaloids in Withania somnifera (L.) Dunal Root Extract Contribute to Its Anti-Inflammatory Activity
2023 Orru', Alessandro; Marchese, Giorgio; Ruiu, Stefania
Ethnomedicine and neuropsychopharmacology in Mesoamerica
2021 Geck, Matthias S.; Lecca, Daniele; Marchese, Giorgio; Casu, Laura; Leonti, Marco
Lights and shadows of schizophrenia therapy research: Lessons from oral risperidone and olanzapine
2020 Nicotra, Ef; Lecca, D; Casu, G; Palomba, M; Sil, A; Marchese, G
On the use of the Positive and Negative Syndrome Scale in randomized clinical trials
2015 Nicotra E.; Casu G.; Piras S.; Marchese G.
VALUTAZIONE DEL RISCHIO E PREVENZIONE DELL'ESORDIO PSICOTICO
2015 Maria Antonietta Casu; Sara Piras; Gianluca Casu; Mario Palomba; Giorgio Marchese
Withania somnifera (L.) Dunal root extract alleviates formalin-induced nociception in mice: involvement of the opioidergic system.
2015 Orrù, A; Casu, Ma; Tambaro, S; Marchese, G; Casu, G; Ruiu, S
Prediction and prevention of the first psychotic episode: New directions and opportunities
2014 Piras, S; Casu, G; Casu, Ma; Orru, A; Ruiu, S; Pilleri, A; Manca, G; Marchese, G
Withania somnifera root extract prolongs analgesia and suppresses hyperalgesia in mice treated with morphine.
2014 Orru', Alessandro; Marchese, Giorgio; Casu, Gianluca; Casu, MARIA ANTONIETTA; Kasture, Sanjay; Cottiglia, Filippo; Acquas, Elio; Mascia, MARIA PAOLA; Anzani, Nicola; Ruiu, Stefania
Synthesis and biological evaluation of novel delta (?) opioid receptor ligands with diazatricyclodecane skeletons
2013 Loriga, G; Lazzari, P; Ruiu, S; Marchese, G; Manca, I; Casu, Gl; Dessi, C; Pinna, Ga; Asproni, B; Murineddu, G
Effects of controlled-release formulations of atypical antipsychotics on functioning and quality of life of schizophrenic individuals
2012 Ruiu, S; Casu, Ma; Casu, G; Piras, S; Marchese, G
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release
2009 Pani, L; Marchese, G
Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration.
2008 Marchese, G; Ruiu, Stefania
Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays
2005 Tambaro, S; Ruiu, S; Dessi, C; Mongeau, R; Marchese, G; Pani, L
Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice.
2004 Casti P; Marchese G; Casu G; Ruiu S; Pani L.
Characterization of wild-type (R100R) and mutated (Q100Q) GABAA a6 subunit in Sardinian alcohol non-preferring rats (sNP).
2003 Sanna, A; Congeddu, E; Porcella, A; Saba, L; Pistis, M; Peis, M; Marchese, G; Grayson, D; Gessa, Gl; Pani, L; Lobina, C
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract.
2003 Casu, Ma; Porcella, A; Ruiu, S; Saba, P; Marchese, G; Carai, Ma; Reali, R; Gessa, Gl; Pani, L
Haloperidol, but not clozapine, produces dramatic catalepsy in Delta9-THC-treated rats: possible clinical implications
2003 Marchese G; Casti P; Ruiu S; Saba P; Sanna A; Casu G; Pani L.
In vitro evidence for the presence of [3H]-haloperidol uptake in rat brain.
2003 Ruiu S.; Marchese G.; Saba PL.; Gessa GL.; Vaccari A.; Pani L.
Molecular characterization of new polymorphisms at the b2, a1, g2 GABAA receptor subunit genes associated to a rat non-preferring ethanol phenotype
2003 Congeddu, E; Saba, L; Porcella, A; Sanna, A; Marchese, G; Lobina, Carla; Gessa, Gl; Pani, L.
Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol
2003 Marchese, G; Bartholini, F; Ruiu, S; Casti, P; Casu, G; Pani, L